The company's purpose is to research, develop, manufacture and distribute worldwide innovative technologies and products in the field of oxygen-carrying solutions, particularly for applications in biotechnology, human and veterinary medicine, as well as blood substitute technology. The focus is on providing alternative oxygen carriers for medical treatment of anemia, organ transplants, and emergency care, where conventional blood transfusions are not possible or not available. The company is authorized to invest as a lead investor in national and international projects and companies with related or complementary business fields, including financing expansions and market launches. The company can form strategic alliances to strengthen the market value and position of partner companies in a targeted manner and establish long-term partnerships. As part of its business activities, the company can establish, operate and expand production facilities for the manufacture of its oxygen-carrying technologies and products, as well as license or lease them to licensees or strategic partner companies to serve market demands flexibly and internationally. The company can acquire, grant and establish exploitation companies or participate in them. It is also authorized to develop, acquire, manage and commercially exploit intellectual property rights, patents, trademarks and other protective rights. The company can establish subsidiaries and branches in Switzerland and abroad, as well as participate in other companies in Switzerland and abroad. To strengthen its financing base, the company is authorized to carry out capital increases, acquire new capital providers and use financial instruments to raise equity capital. The company can also provide financing for its own or third-party account and assume guarantees and warranties for affiliated companies and strategic partners to jointly exploit market opportunities. Furthermore, the company is authorized to conduct all business and take all measures that appear suitable to promote the company's purpose directly or indirectly. It can acquire, encumber, sell and manage properties in Switzerland and abroad, as well as engage in any activities that promote the well-being and growth of the company.
Outbound Leads by COHAGA